147 related articles for article (PubMed ID: 23184207)
1. Relationship between plasminogen activator inhibitor type-1 (PAI-1) gene polymorphisms and osteoporosis in Turkish women.
Ozgen M; Cosan DT; Doganer F; Soyocak A; Armagan O; Gunes HV; Degirmenci I; Ozkara GO; Mutlu FS
Clinics (Sao Paulo); 2012 Nov; 67(11):1299-302. PubMed ID: 23184207
[TBL] [Abstract][Full Text] [Related]
2. Tissue plasminogen activator and plasminogen activator inhibitor-1 gene polymorphisms in patients with chronic periodontitis.
Gürkan A; Emingil G; Saygan BH; Cinarcik S; Atilla G; Köse T; Berdeli A
J Periodontol; 2007 Jul; 78(7):1256-63. PubMed ID: 17608581
[TBL] [Abstract][Full Text] [Related]
3. Lack of association between plasminogen activator inhibitor type-1 (PAI-1) gene 4G/5G polymorphism and osteoarthritis.
Bayram B; Sayin E; Erkasap N; Onlü H; Ozkurt M; Sahin F; Türkoğlu Z
Rheumatol Int; 2012 Jan; 32(1):259-62. PubMed ID: 21240498
[TBL] [Abstract][Full Text] [Related]
4. Gene polymorphisms of tissue plasminogen activator and plasminogen activator inhibitor-1 in Turkish patients with generalized aggressive periodontitis.
Emingil G; Berdeli A; Gürkan A; Han Saygan B; Köse T; Atilla G
J Clin Periodontol; 2007 Apr; 34(4):278-84. PubMed ID: 17257155
[TBL] [Abstract][Full Text] [Related]
5. Promotor polymorphisms of plasminogen activator inhibitor-1 and other thrombophilic genotypes in cerebral venous thrombosis: a case-control study in adults.
Ringelstein M; Jung A; Berger K; Stoll M; Madlener K; Klötzsch C; Schlachetzki F; Stolz E
J Neurol; 2012 Nov; 259(11):2287-92. PubMed ID: 22527222
[TBL] [Abstract][Full Text] [Related]
6. Relationship of plasminogen activator inhibitor 1 gene 4G/5G polymorphisms to hypertension in Korean women.
Kim KN; Kim KM; Kim BT; Joo NS; Cho DY; Lee DJ
Chin Med J (Engl); 2012 Apr; 125(7):1249-53. PubMed ID: 22613596
[TBL] [Abstract][Full Text] [Related]
7. A study of the possible association of plasminogen activator inhibitor type 1 4G/5G insertion/deletion polymorphism with susceptibility to schizophrenia and in its subtypes.
Yenilmez C; Ozdemir Koroglu Z; Kurt H; Yanas M; Colak E; Degirmenci I; Gunes HV
J Clin Pharm Ther; 2017 Feb; 42(1):103-107. PubMed ID: 27796029
[TBL] [Abstract][Full Text] [Related]
8. Plasminogen activator inhibitor type-1 gene 4G/5G polymorphism is associated with hypertensive patients in the Turkish population.
Gunes HV; Cosan DT; Ata N; Birdane A; Ustuner MC; Dikmen M; Bayram B; Degirmenci I
Genet Test Mol Biomarkers; 2010 Jun; 14(3):303-5. PubMed ID: 20392162
[TBL] [Abstract][Full Text] [Related]
9. Plasminogen activator inhibitor-1 gene 4G/5G polymorphism in Turkish children with asthma and allergic rhinitis.
Ozbek OY; Ataç FB; Ogus E; Ozbek N
Allergy Asthma Proc; 2009; 30(1):41-6. PubMed ID: 19063817
[TBL] [Abstract][Full Text] [Related]
10. Association of PAI-1 4G/5G and -844G/A gene polymorphisms and changes in PAI-1/tissue plasminogen activator levels in myocardial infarction: a case-control study.
Abboud N; Ghazouani L; Saidi S; Ben-Hadj-Khalifa S; Addad F; Almawi WY; Mahjoub T
Genet Test Mol Biomarkers; 2010 Feb; 14(1):23-7. PubMed ID: 19929406
[TBL] [Abstract][Full Text] [Related]
11. Plasminogen activator inhibitor-1 gene polymorphism 4G/4G genotype and lupus nephritis in Chinese patients.
Wang AY; Poon P; Lai FM; Yu L; Choi PC; Lui SF; Li PK
Kidney Int; 2001 Apr; 59(4):1520-8. PubMed ID: 11260416
[TBL] [Abstract][Full Text] [Related]
12. Role of the tissue-type plasminogen activator -7351C > T and plasminogen activator inhibitor 1 4G/5G gene polymorphisms in central serous chorioretinopathy.
Malle EM; Posch-Pertl L; Renner W; Pinter-Hausberger S; Singer C; Haas A; Wedrich A; Weger M
Ophthalmic Genet; 2018 Dec; 39(6):714-716. PubMed ID: 30442055
[TBL] [Abstract][Full Text] [Related]
13. Plasminogen activator inhibitor type-1 gene 4G/5G polymorphism in Turkish adult patients with asthma.
Cosan D; Kurt E; Kurt H; Degirmenci I; Kuçukarabaci B; Metintas M; Kucuk MU; Gunes HV; Colak E
Genet Test Mol Biomarkers; 2009 Aug; 13(4):543-6. PubMed ID: 19604112
[TBL] [Abstract][Full Text] [Related]
14. The prevalence of 4G5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in polycystic ovarian syndrome and its association with plasma PAI-1 levels.
Diamanti-Kandarakis E; Palioniko G; Alexandraki K; Bergiele A; Koutsouba T; Bartzis M
Eur J Endocrinol; 2004 Jun; 150(6):793-8. PubMed ID: 15191349
[TBL] [Abstract][Full Text] [Related]
15. The effect of plasminogen activator inhibitor-1 gene 4G/5G polymorphism on glucose and lipid metabolisms in Turkish obese children.
Kinik ST; Ataç FB; Verdi H; Cetintaş S; Sahin FI; Ozbek N
Clin Endocrinol (Oxf); 2005 May; 62(5):607-10. PubMed ID: 15853833
[TBL] [Abstract][Full Text] [Related]
16. The plasminogen activator inhibitor 1 4G/5G polymorphism is not associated with longevity: a study in octogenarians.
Lottermoser K; Düsing R; Ervens P; Koch B; Brüning T; Sachinidis A; Vetter H; Ko Y
J Mol Med (Berl); 2001 Jun; 79(5-6):289-93. PubMed ID: 11485022
[TBL] [Abstract][Full Text] [Related]
17. Association of Plasminogen Activator Inhibitor-1 (PAI-1) Gene Polymorphisms with Osteoporotic Vertebral Compression Fractures (OVCFs) in Postmenopausal Women.
Kim JO; Han SH; Lee YH; Ahn TK; Lim JJ; Chung YS; Shin DE; Lee WS; Han IB; Kim NK
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27941685
[TBL] [Abstract][Full Text] [Related]
18. PAI-1 and tPA gene polymorphisms and susceptibility to chronic obstructive pulmonary disease in a sample of Turkish population.
Sunnetcioglu A; Berkoz M; Yildirim M; Bora G; Yalin S
J Pak Med Assoc; 2020 Dec; 70(12(B)):2310-2315. PubMed ID: 33475534
[TBL] [Abstract][Full Text] [Related]
19. Promoter (4G/5G) plasminogen activator inhibitor-1 genotype and plasminogen activator inhibitor-1 levels in blacks, Hispanics, and non-Hispanic whites: the Insulin Resistance Atherosclerosis Study.
Festa A; D'Agostino R; Rich SS; Jenny NS; Tracy RP; Haffner SM
Circulation; 2003 May; 107(19):2422-7. PubMed ID: 12719278
[TBL] [Abstract][Full Text] [Related]
20. Plasminogen activator inhibitor-1 and susceptibility to lung cancer: a population genetics perspective.
Bayramoglu A; Gunes HV; Metintas M; Degirmenci I; Guler HI; Ustuner C; Musmul A
Genet Test Mol Biomarkers; 2014 Aug; 18(8):587-90. PubMed ID: 24955483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
